Exposure to environmental lead (Pb) is a mild risk factor for amyotrophic lateral sclerosis (ALS), a paralytic disease characterized by progressive degeneration of motor neurons. However, recent evidence has paradoxically linked higher Pb levels in ALS patients with longer survival. We investigated the effects of lowlevel Pb exposure on survival of mice expressing the ALS-linked superoxide dismutase-1 G93A mutation (SOD1
G93A
). SOD1 G93A mice exposed to Pb showed longer survival and increased expression of VEGF in the ventral horn associated with reduced astrocytosis. Pretreatment of cultured SOD1 G93A astrocytes with low, non toxic Pb concentrations upregulated VEGF expression and significantly abrogated motor neuron loss in coculture, an effect prevented by neutralizing antibodies to VEGF. The actions of Pb on astrocytes might explain its paradoxical slowing of disease progression in SOD1 G93A mice and the improved survival of ALS patients. Understanding how Pb stimulates astrocytic VEGF production and reduces neuroinflammation may yield a new therapeutic approach for treating ALS. © 2009 Elsevier Inc. All rights reserved.
Introduction
Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disorder characterized by the selective death of motor neurons, resulting in progressive paralysis and death. The cause of the disease remains unknown for the majority of sporadic cases of ALS. The discovery of missense mutations in the gene encoding the antioxidant enzyme Cu/Zn superoxide dismutase-1 (SOD1) in a subset of patients with familial ALS (Rosen et al., 1993 ) stimulated research in transgenic animal models expressing different SOD1 mutations though the pathogenic mechanism underlying the toxicity of SOD1 mutants remains controversial.
Studies in transgenic mice have shown evidence for a non-cell autonomous toxicity of SOD1 mutations. Decreasing mutant SOD1 expression in astrocytes or microglia (Boillee et al., 2006; Yamanaka et al., 2008) , and grafting wild-type macrophages to mutant SOD1 mice (Beers et al., 2006) , increase the lifespan of mutant SOD1 mice. In addition, in vitro studies have shown that astrocytes expressing the SOD1 G93A mutation exert toxic influence to non-transgenic motor neurons (Vargas et al., 2006; Nagai et al., 2007; Di Giorgio et al., 2007; Cassina et al., 2008) , suggesting that these glial cells can play a disease-modifying role in ALS pathogenesis (Barbeito et al., 2004) . Occupational or environmental exposure to a variety of toxicants including heavy metals has been evaluated as potential causes of ALS. Exposure to the heavy metal lead (Pb) and in particular blood and bone content of Pb was associated with an increased risk of ALS (Kamel et al., 2005) . More recently, epidemiological data also showed that Pb blood and bone levels positively correlate with longer survival in ALS patients after diagnosis (Kamel et al., 2008) , suggesting Pb exposure may paradoxically delay the disease progression.
Pb is a widely spread environmental heavy metal with no known specific biological function. Pb has been shown to induce acute and chronic neurotoxicity, particularly during CNS development (Cory-Slechta and Pound, 1995; Bellinger, 2008) . Both neuronal and glial cells seem to be affected in Pb neurotoxicity (Tiffany-Castiglioni and Qian, 2001 ). However, the toxicity of Pb on spinal cord motor neurons and astrocytes is presently unknown as is its potential role in the etiology of ALS.
Experimental evidence supports the view that astrocytes can sequester and buffer Pb in the CNS, preventing further diffusion of the metal to the neuronal compartment and subsequent neurotoxicity or altered synaptic transmission (Tiffany-Castiglioni, 1993; TiffanyCastiglioni and Qian, 2001 ). In particular, astrocytes are the cells that preferentially induce cytoprotective and antioxidant gene expression in response to Pb (Cabell et al., 2004) . Thus, available Neurobiology of Disease 37 (2010) [574] [575] [576] [577] [578] [579] [580] 
